6-(6-azaspiro[3.5]nonan-6-yl)-N-[[2-fluoro-3-(1-fluoroethyl)phenyl]methyl]-2-methylpyrido[3,4-d]pyrimidin-4-amine
C25H29F2N5 — CID 156726415
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-(6-azaspiro[3.5]nonan-6-yl)-N-[[2-fluoro-3-(1-fluoroethyl)phenyl]methyl]-2-methylpyrido[3,4-d]pyrimidin-4-amine
6-(6-azaspiro[3.5]nonan-6-yl)-N-[[2-fluoro-3-(1-fluoroethyl)phenyl]methyl]-2-methylpyrido[3,4-d]pyrimidin-4-amine (PubChem CID 156726415) has the molecular formula C25H29F2N5 and a molecular weight of 437.54 g/mol. Its IUPAC name is 6-(6-azaspiro[3.5]nonan-6-yl)-N-[[2-fluoro-3-(1-fluoroethyl)phenyl]methyl]-2-methylpyrido[3,4-d]pyrimidin-4-amine.
Molecular Properties
| Compound Name | 6-(6-azaspiro[3.5]nonan-6-yl)-N-[[2-fluoro-3-(1-fluoroethyl)phenyl]methyl]-2-methylpyrido[3,4-d]pyrimidin-4-amine |
|---|---|
| PubChem CID | 156726415 |
| Molecular Formula | C25H29F2N5 |
| Molecular Weight | 437.54 g/mol |
| Exact Mass | 437.24 |
| IUPAC Name | 6-(6-azaspiro[3.5]nonan-6-yl)-N-[[2-fluoro-3-(1-fluoroethyl)phenyl]methyl]-2-methylpyrido[3,4-d]pyrimidin-4-amine |
| SMILES | Cc1nc(NCc2cccc(C(C)F)c2F)c2cc(N3CCCC4(CCC4)C3)ncc2n1 |
| InChI | InChI=1S/C25H29F2N5/c1-16(26)19-7-3-6-18(23(19)27)13-29-24-20-12-22(28-14-21(20)30-17(2)31-24)32-11-5-10-25(15-32)8-4-9-25/h3,6-7,12,14,16H,4-5,8-11,13,15H2,1-2H3,(H,29,30,31) |
| InChIKey | MYJIESPAZUESIB-UHFFFAOYSA-N |
| XLogP | 5.89 |
| TPSA | 53.94 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 437.54 |
| LogP ≤ 5 | 5.89 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156726415 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.